These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
799 related articles for article (PubMed ID: 27018801)
1. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Tuttle MD; Comellas G; Nieuwkoop AJ; Covell DJ; Berthold DA; Kloepper KD; Courtney JM; Kim JK; Barclay AM; Kendall A; Wan W; Stubbs G; Schwieters CD; Lee VM; George JM; Rienstra CM Nat Struct Mol Biol; 2016 May; 23(5):409-15. PubMed ID: 27018801 [TBL] [Abstract][Full Text] [Related]
2. Structural comparison of mouse and human α-synuclein amyloid fibrils by solid-state NMR. Lv G; Kumar A; Giller K; Orcellet ML; Riedel D; Fernández CO; Becker S; Lange A J Mol Biol; 2012 Jun; 420(1-2):99-111. PubMed ID: 22516611 [TBL] [Abstract][Full Text] [Related]
3. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study. Sanjeev A; Mattaparthi VSK Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628 [TBL] [Abstract][Full Text] [Related]
4. Characterization of fibrillation process of alpha-synuclein at the initial stage. Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence. Kang L; Janowska MK; Moriarty GM; Baum J PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647 [TBL] [Abstract][Full Text] [Related]
6. Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K. Lemkau LR; Comellas G; Lee SW; Rikardsen LK; Woods WS; George JM; Rienstra CM PLoS One; 2013; 8(3):e49750. PubMed ID: 23505409 [TBL] [Abstract][Full Text] [Related]
7. Cryo-EM structure of alpha-synuclein fibrils. Guerrero-Ferreira R; Taylor NM; Mona D; Ringler P; Lauer ME; Riek R; Britschgi M; Stahlberg H Elife; 2018 Jul; 7():. PubMed ID: 29969391 [TBL] [Abstract][Full Text] [Related]
8. The fold of alpha-synuclein fibrils. Vilar M; Chou HT; Lührs T; Maji SK; Riek-Loher D; Verel R; Manning G; Stahlberg H; Riek R Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8637-42. PubMed ID: 18550842 [TBL] [Abstract][Full Text] [Related]
9. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Conway KA; Harper JD; Lansbury PT Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160 [TBL] [Abstract][Full Text] [Related]
11. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy. Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316 [TBL] [Abstract][Full Text] [Related]
12. Covalent α-synuclein dimers: chemico-physical and aggregation properties. Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053 [TBL] [Abstract][Full Text] [Related]
13. Structure of the toxic core of α-synuclein from invisible crystals. Rodriguez JA; Ivanova MI; Sawaya MR; Cascio D; Reyes FE; Shi D; Sangwan S; Guenther EL; Johnson LM; Zhang M; Jiang L; Arbing MA; Nannenga BL; Hattne J; Whitelegge J; Brewster AS; Messerschmidt M; Boutet S; Sauter NK; Gonen T; Eisenberg DS Nature; 2015 Sep; 525(7570):486-90. PubMed ID: 26352473 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the 3D structures of mouse and human α-synuclein fibrils by solid-state NMR and STEM. Hwang S; Fricke P; Zinke M; Giller K; Wall JS; Riedel D; Becker S; Lange A J Struct Biol; 2019 Apr; 206(1):43-48. PubMed ID: 29678776 [TBL] [Abstract][Full Text] [Related]
15. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils. Yang X; Wang B; Hoop CL; Williams JK; Baum J Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234 [TBL] [Abstract][Full Text] [Related]
16. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499 [TBL] [Abstract][Full Text] [Related]
17. Structured regions of α-synuclein fibrils include the early-onset Parkinson's disease mutation sites. Comellas G; Lemkau LR; Nieuwkoop AJ; Kloepper KD; Ladror DT; Ebisu R; Woods WS; Lipton AS; George JM; Rienstra CM J Mol Biol; 2011 Aug; 411(4):881-95. PubMed ID: 21718702 [TBL] [Abstract][Full Text] [Related]
18. In silico investigation of the structural stability as the origin of the pathogenicity of Yoon J; Lee M; Park Y; Lee K; Shin S J Biomol Struct Dyn; 2023; 41(23):14103-14115. PubMed ID: 37036430 [No Abstract] [Full Text] [Related]
19. Molecular structures of amyloid and prion fibrils: consensus versus controversy. Tycko R; Wickner RB Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335 [TBL] [Abstract][Full Text] [Related]
20. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Uversky VN; Eliezer D Curr Protein Pept Sci; 2009 Oct; 10(5):483-99. PubMed ID: 19538146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]